Insider Insights
06.12.2022
France – Clinical trials: an improved 2021 but t...

France have improved the conduction of clinical trials in 2021, due to the reduction of regulatory d...

Read more
Insider Insights
06.12.2022
UK NHS England set to eliminate hepatitis C by 203...

NHS England has reported that following a 5-year £1b antiviral drugs deal, deaths from Hepatitis C ...

Read more
Insider Insights
04.11.2022
UK: NICE conditionally recommends digital cognitiv...

NICE guidance published today on digital health technologies suggest they can be used to help young ...

Read more
Insider Insights
01.11.2022
Germany – Is digitisation the gateway to better ...

Digitisation is thought to contribute significant improvements in knowledge generation in drug devel...

Read more
Insider Insights
01.11.2022
Germany: Significant interest has been aroused by ...

The G-BA Innovation Committee will evaluate which projects will receive funding, with advice being c...

Read more
Insider Insights
01.11.2022
A winter of discontent? European pharmaceutical so...

EUCOPE and EFPIA have issued a joint statement expressing concerns regarding the implementation of t...

Read more
Insider Insights
27.10.2022
France: Biologists take strike action against PLFS...

The Article outlined in the PLFSS requires laboratories to lower the prices of their routine examina...

Read more
Insider Insights
27.10.2022
Financial Stabilisation Act is passed, sparks crit...

This law is projected to have a large impact on the pharmaceutical industry and pharmacies nationwid...

Read more
Insider Insights
18.10.2022
US Pharma Amylyx in hot water over exorbitant pric...

Amylyx has set the annual price of the ALS drug to $158,000, whereas ICER have suggested the drug sh...

Read more
Insider Insights
18.10.2022
UK Agencies join with International HTA Partners f...

A cross-border alliance of health technology assessment (HTA) agencies has been announced by the Can...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.